期刊文献+

我国新疆地区不同糖代谢状态与恶性肿瘤患病风险的相关性研究

Correlation of glucose tolerance status with risk of cancer in Xinjiang,China
原文传递
导出
摘要 目的:研究不同的糖代谢状态下,我国新疆地区人群恶性肿瘤的患病风险。方法 :采用横断面研究,将9 707名新疆地区40岁以上的社区人群分为正常糖耐量、糖耐量异常和糖尿病3组,分析不同糖代谢状态与恶性肿瘤患病风险间的关系,并按照性别进行亚组分析。结果:在总人群中对糖代谢状态与恶性肿瘤患病风险进行Logistic回归分析,结果表明,在校正吸烟、饮酒、肿瘤家族史等因素后,不同糖代谢状态与恶性肿瘤患病率之间并未观察到相关性。亚组分析显示,女性糖耐量异常人群和糖尿病患者的恶性肿瘤患病风险分别增加43%和45%[比值比(odds ratio,OR)分别为1.43和1.45,95%可信区间(confidence interval,CI)分别为1.03~1.98和1.00~2.11],但在男性中,均未见两者间存在相关性。结论:在新疆地区中老年社区女性人群中,糖耐量异常及糖尿病均与恶性肿瘤患病风险的升高相关。有关糖尿病病程、降糖治疗、血糖控制情况等与恶性肿瘤发生风险之间关系有待进一步长期随访研究证实。 Objective: To determine whether glucose tolerance status is associated with increased risk of cancer in the Xinjiang population. Methods: A total of 9707 community-resident adults, aged 40 or older, were enrolled in this cross-sectional survey. According to glucose tolerance status, participants were classified into three groups: normal glucose metabolism, impaired glucose tolerance(IGT) and diabetes. Relationship between glucose tolerance status and risk of can-cer was investigated, and was further studied between male and female. Results: Logistic regression analysis revealed that IGT and diabetes conferred 43% and 45% higher risk of cancer, respectively(OR: 1.43, 95%CI: 1.03-1.98 for IGT; OR:1.45, 95%CI: 1.00-2.11 for diabetes) in females. However, the higher risk of cancer was not detected in males. Conclusions:Diabetes is associated with an increased risk of cancer in Xingjiang females aged 40 or older, which is independent to other risk factors of cancer. Long-term follow-up study is needed to confirm the correlation of diabetes duration, antidiabetic therapy, glycemia control with the risk of cancer.
出处 《诊断学理论与实践》 2016年第3期274-279,共6页 Journal of Diagnostics Concepts & Practice
基金 克拉玛依市科学技术局项目(2011SK-25)
关键词 糖尿病 恶性肿瘤 新疆维吾尔族 REACTION研究 Diabetes Cancer Xingjiang Uyghur REACTION study
  • 相关文献

参考文献16

  • 1Unwin N, Gan D, Whiting D. The IDF Diabetes Atlas: providing evidence, raising awareness and promoting ac- tion[J]. Diabetes Res Clin Pract,2010,87(1):2-3.
  • 2Xu Y, Wang L, He J, et al. Prevalence and control of dia- betes in Chinese adults[J]. JAMA,2013,310(9):948-959.
  • 3Kuriki K, Hirose K, Tajima K. Diabetes and cancer risk for all and specific sites among Japanese men and women [J]. Eur J Cancer Prey,2007,16(1):83-89.
  • 4de Bruijn KM, Arends LR, Hansen BE, et al. Systematic reTiew and meta-analysis of the association between dia- betes mellitus and incidence and mortality in breast and colorectal cancer[J]. Br J Surg,2013,100(11):1421-1429.
  • 5Adami HO, Chow WH, Nyr6n O, et al. Excess risk of pri- mary liver cancer in patients with diabetes mellitus[J]. J Natl Cancer Inst,1996,88(20):1472-1477.
  • 6Gallagher [J, LeRoith D. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?[J]. Curr Opin Endocrinol Diabetes Obes,2013,20(5):485-494.
  • 7Xu HL, Tan YT, Epplein M, et al.Population-based co- hort studies of type 2 diabetes and stomach cancer risk in Chinese men and women[J]. Cancer Sci,2015,106(3): 294-298.
  • 8Yang WS, Yang Y, Yang G, et al. Pre-existing type 2 dia- betes and risk of lung cancer: a report from two prospec- tive cohort studies of 133024 Chinese adults in urban Shanghai[J]. BMJ Open,2014,4(7):eO04875.
  • 9杜瑞,陆洁莉,毕宇芳,宁光.降糖药物治疗与恶性肿瘤[J].中华内分泌代谢杂志,2016,32(3):253-256. 被引量:4
  • 10Warburg O. Photosynthesis[J]. Science,1958,128(3315): 68-73.

二级参考文献39

  • 1Y Xu, L Wang, J He, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013,310(9) :948-959.
  • 2Home PD, Kahn SE, Jones NP, et al. Experience of malignancies with oral glucose-lowering drugs in the randomized controlled ADOPT ( A Diabetes Outcome Progression Trial ) and RECORD ( Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials[ J]. Diabetologia, 2010,53 (9) : 1838-1845.
  • 3Bi Y, Lu J, Wang W, et al. Cohort profile: Risk evaluation of cancersin Chinese diabetic individuals: a longitudinal (REACTION) study [J]. J Diabetes, 2014,6(2) :147-157.
  • 4Warburg O. Photosynthesis [ J 1. Science, 1958,128 ( 3315 ) :68-73.
  • 5Hamanaka RB, Chandel NS. Cell biolo. Warburg effect and rednx balance [ J ]. Science, 2011,334 (6060) : 1219-1220.
  • 6Taubes G. Cancer research. Unraveling the obesity-emacer connection [ J ]. Science, 2012,335 ( 6064 ) :28,30-32.
  • 7Chang CH, Lin JW, Wu LC, et al. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus [ J ]. Hepatology, 2012,55 ( 5 ) : 1462-1472.
  • 8Wang F, Zhao SZ, Zhang MY, et al. Decreased risk of liver cancer with thiazolidinediones therapy in patients with type 2 diabetes : Results from a meta-analysis [ J ]. Hepatology, 2013,58 ( 2 ) : 835-836.
  • 9Galli A, Ceni E, Mello T, et al. Thiazolidinediones inhibit hepatoearcinogenesis in hepatitis B virus-transgenie mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleopbesmin [ J ]. Hepatology, 2010,52 ( 2 ) :493-505.
  • 10Dormandy JA, Charbonnel B, Eckland DJ, et al. Secondary prevention of maerovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In maeroVascular Events) : a randomised controlled trial [ J ]. Lancet, 2005,366 ( 10 ) : 1279-1289.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部